NASDAQ: ORKA · Health Care / Biotechnology: In Vitro & In Vivo Diagnostic Substances

Oruka Therapeutics Inc.

How Oruka Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$6.4B

Price

$96.65

P/E

-44.4

EPS (TTM)

$-2.18

1-year return

250.1%

Dividend yield

0.0%

52-week range

$26.99–$96.65

Compared with

• Biotechnology: In Vitro & In Vivo Diagnostic Substances industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources